Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M36.8Revenue $M0.4Net Margin (%)-1,800.0Z-Score3.6
Enterprise Value $M12.5EPS $-1.3Operating Margin %-1,816.8F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-1,800.0Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %0Quick Ratio12.9Cash flow > EarningsY
Price/Sales44.45-y EBITDA Growth Rate %-58.6Current Ratio12.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-53.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-57.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M11.2ROI % (ttm)-70.6Gross Margin Increase y-yN

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ROSG is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

    Quarterly/Annual Reports about ROSG:

      News about ROSG:

      Articles On GuruFocus.com
      Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance Nov 18 2014 
      Rosetta Genomics Reports Second Quarter Financial Results, Provides Business Update Sep 08 2009 
      Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd. Jan 08 2009 
      Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

      More From Other Websites
      Rosetta Genomics to Present at the 27th Annual ROTH Conference Mar 04 2015
      Rosetta Genomics to Present at the 27th Annual ROTH Conference Mar 04 2015
      Nasdaq stocks posting largest volume increases Mar 03 2015
      Rosetta Genomics’ Novel and Differentiated Thyroid Cancer Assay Moves to Advanced Stages of... Feb 26 2015
      Rosetta Genomics’ Novel and Differentiated Thyroid Cancer Assay Moves to Advanced Stages of... Feb 26 2015
      ROSG: Broad Patent Allowances Assure Sustainable Growth Feb 20 2015
      Rosetta Genomics (ROSG) Stock Sells Off Today Following Tuesday's Surge Feb 18 2015
      One ETF Gets a Lift From Rosetta Genomics Feb 17 2015
      Rosetta Genomics (ROSG) Stock Soars Today After Patent Allowance Announcements Feb 17 2015
      Rosetta Genomics Announces Key Patent Allowances in U.S. and Europe Feb 17 2015
      Rosetta Genomics Announces Key Patent Allowances in U.S. and Europe Feb 17 2015
      Rosetta Genomics Receives First Patent Allowance in Japan Feb 10 2015
      Rosetta Genomics Receives First Patent Allowance in Japan Feb 10 2015
      Rosetta Genomics Announces Commercial Partnership with Precipio Diagnostics Feb 09 2015
      Rosetta Genomics Announces Commercial Partnership with Precipio Diagnostics Feb 09 2015
      Clinician Survey Supporting Value Proposition of the Rosetta Kidney Cancer Test™ Published in the... Jan 20 2015
      Clinician Survey Supporting Value Proposition of the Rosetta Kidney Cancer Test™ Published in the... Jan 20 2015
      Rosetta Genomics Issues Letter to Shareholders Jan 12 2015
      Rosetta Genomics Issues Letter to Shareholders Jan 12 2015
      Rosetta Genomics Announces Launch of Admera Health’s Sequencing-Based Oncology Tests Jan 08 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK